Serum lipids in patients with Hodgkin's disease in complete remission

被引：4
|
作者：
Munker, R [1 ]
Cremer, P [1 ]
Fries, S [1 ]
Hiller, E [1 ]
机构：
[1] UNIV MUNICH,KLINIKUM GROSSHADERN,MED KLIN 3,INST KLIN CHEM,D-81366 MUNICH,GERMANY
来源：
ACTA ONCOLOGICA | 1997年 / 36卷 / 01期
关键词：
D O I：
10.3109/02841869709100737
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：75 / 77
页数：3
相关论文
共 50 条
  • [41] Poor clinical outcome of patients with Hodgkin's Disease and elevated interleukin-10 serum levels Clinical significance of interleukin-10 serum levels for Hodgkin's disease
    H. Bohlen
    M. Kessler
    M. Sextro
    V. Diehl
    H. Tesch
    Annals of Hematology, 2000, 79 : 110 - 113
  • [42] Comparative study on complete remission rate and overall survival in three groups classified based on the serum interleukin-18 level in non-Hodgkin's lymphoma patients
    Takubo, T
    Kumura, T
    Nakao, T
    Nakamae, H
    Aoyama, Y
    Nishiki, S
    Kinoshita, Y
    Koh, KR
    Ohta, K
    Yamane, T
    Hino, M
    Kamitani, T
    Tatsumi, N
    ACTA HAEMATOLOGICA, 2000, 104 (04) : 220 - 222
  • [43] Limited Utility of Routine Surveillance Imaging for Classical Hodgkin Lymphoma Patients in First Complete Remission
    Pingali, Sai Ravi
    Jewell, Sarah W.
    Havlat, Luiza
    Bast, Martin A.
    Thompson, Jonathan R.
    Eastwood, Daniel C.
    Bartlett, Nancy L.
    Armitage, James O.
    Wagner-Johnston, Nina D.
    Vose, Julie M.
    Fenske, Timothy S.
    CANCER, 2014, 120 (14) : 2122 - 2129
  • [44] CORONARY HEART DISEASE AND SERUM LIPIDS IN HYPERTENSIVE PATIENTS
    NYE, ER
    JOURNAL OF ATHEROSCLEROSIS RESEARCH, 1966, 6 (01): : 18 - &
  • [45] SERUM AND LIVER LIPIDS IN PATIENTS WITH AND WITHOUT LIVER DISEASE
    BILLING, BH
    HASLAM, RM
    HEIN, DE
    CONLON, HJ
    HAMILTON, DL
    MINDRUM, GM
    SCHIFF, L
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1955, 45 (03): : 363 - 370
  • [46] Case report: Sustained complete remission with all-oral MEPED therapy in a patient with Hodgkin's disease developing resistance to pembrolizumab
    Reuthner, K.
    Aubele, P.
    Menhart, K.
    Rath, P.
    Harrer, D. C.
    Herr, W.
    Hahn, J.
    Vogelhuber, M.
    Heudobler, D.
    Lueke, F.
    Reichle, A.
    Grube, M.
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [47] Consolidation radiation after complete remission in Hodgkin's disease following six cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy: Is there a need?
    Laskar, S
    Gupta, T
    Vimal, S
    Muckaden, MA
    Saikia, TK
    Pai, SK
    Naresh, KN
    Dinshaw, KA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (01) : 62 - 68
  • [48] High-dose therapy and autologous bone marrow transplantation in first complete or partial remission for poor prognosis Hodgkin's disease
    Fleury, J
    Legros, M
    Colombat, P
    Cure, H
    Travade, P
    Tortochaux, J
    Dionet, C
    Chollet, P
    Linassier, C
    Lamagnere, JP
    Blaise, D
    Viens, P
    Maraninchi, D
    Plagne, R
    LEUKEMIA & LYMPHOMA, 1996, 20 (3-4) : 259 - 266
  • [49] Poor clinical outcome of patients with Hodgkin's Disease and elevated interleukin-10 serum levels - Clinical significance of interleukin-l0 serum levels for Hodgkin's disease
    Bohlen, H
    Kessler, M
    Sextro, M
    Diehl, V
    Tesch, H
    ANNALS OF HEMATOLOGY, 2000, 79 (03) : 110 - 113
  • [50] Multiple cutaneous granular cell tumors in a child in remission for Hodgkin's disease
    De Raeve, L
    Roseeuw, D
    Otten, J
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 47 (02) : S180 - S182
12345